Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.450
+0.020 (0.82%)
Aug 29, 2025, 4:00 PM - Market closed
Alzamend Neuro Stock Forecast
ALZN's stock price has decreased by -89.37% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Alzamend Neuro stock has a target of 45, which predicts a 1,736.73% increase from the current stock price of 2.45.
Price Target: $45 (+1,736.73%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Alzamend Neuro is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $180 → $45 | Strong Buy | Maintains | $180 → $45 | +1,736.73% | Aug 21, 2025 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $288 → $180 | Strong Buy | Maintains | $288 → $180 | +7,246.94% | Mar 17, 2025 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $315 → $288 | Strong Buy | Maintains | $315 → $288 | +11,655.10% | Dec 16, 2024 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $450 → $315 | Strong Buy | Maintains | $450 → $315 | +12,757.14% | Nov 11, 2024 |
Maxim Group | Maxim Group | Strong Buy Initiates $2,025 | Strong Buy | Initiates | $2,025 | +82,553.06% | Apr 12, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.98
from -11.32
EPS Next Year
-5.20
from -4.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|
High | n/a | n/a | |||
Avg | n/a | n/a | |||
Low | n/a | n/a |
Revenue Growth
Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|
High | - | - | |||
Avg | - | - | |||
Low | - | - |
EPS Forecast
EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|
High | -3.17 | -3.05 | |||
Avg | -4.98 | -5.20 | |||
Low | -6.62 | -7.14 |
EPS Growth
EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|
High | - | - | |||
Avg | - | - | |||
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.